US Republicans fail to repeal health care reform in Senate; Medical liability bill slammed

3 February 2011

As had been largely expected, the USA’s Republican Senators failed to get enough votes to repeal President Barack Obama’s signature health care reform law in a 47-51 party-line vote. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote. The House of Representatives, where Republicans have a majority, voted to repeal the legislation last month (The Pharma Letter January 20 and 25).

"Senate Republican leader Mitch McConnell, quoted by the Associated Press, said the vote marked an opportunity for Democrats who voted for the bill last year 'to listen to those who have desperately been trying to get your attention. To say, yes, maybe my vote for this bill was a mistake, and that we can do better.”

According to a report in the UK’s Financial Times, most analysts agree that the fate of the Affordable Care Act will be determined not in Congress but in the Supreme Court. The court is expected to hear and rule on the case next year - an election year - laying the groundwork for a decision with far-reaching political implications. Its deliberations will focus on one question: whether the federal government can force individuals to buy health insurance.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical